PARSIPPANY, N.J.--(BUSINESS WIRE)--Aug. 3, 2015--
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Dave
Stack, president, chief executive officer and chairman of Pacira
Pharmaceuticals, is scheduled to present an overview of the company at
the following investor conferences in August:
Wedbush 2015 Life Sciences Management Access Conference at 8:00 a.m.
ET in New York on Tuesday, August 11, 2015.
Canaccord Genuity’s 35th Annual Growth Conference at 9:00 a.m. ET in
Boston on Wednesday, August 12, 2015.
Live audio webcasts of the Pacira presentations can be accessed by
visiting the “Investors & Media” section of the company’s website at
investor.pacira.com. Replays of the webcasts will be archived on the
Pacira website for two weeks following the respective presentation dates.
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated for
single-dose infiltration into the surgical site to produce postsurgical
analgesia, was commercially launched in the United States in April 2012.
EXPAREL and two other products have successfully utilized DepoFoam®, a
unique and proprietary product delivery technology that encapsulates
drugs without altering their molecular structure, and releases them over
a desired period of time. Additional information about Pacira is
available at www.pacira.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150803005111/en/
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
Jessica Cho, 973-254-3574